Trexquant Investment LP - REATA PHARMACEUTICALS INC ownership

REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 202 filers reported holding REATA PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 1.43 and the average weighting 0.5%.

Quarter-by-quarter ownership
Trexquant Investment LP ownership history of REATA PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2022$613,349
+199.2%
16,145
+683.7%
0.02%
-10.5%
Q1 2021$205,000
-19.0%
2,060
+0.5%
0.02%
-29.6%
Q4 2020$253,000
-3.4%
2,049
-37.3%
0.03%
+17.4%
Q3 2019$262,000
-54.1%
3,267
-51.1%
0.02%
-43.9%
Q1 2019$571,000
-10.4%
6,682
-41.2%
0.04%
+2.5%
Q4 2018$637,00011,3630.04%
Other shareholders
REATA PHARMACEUTICALS INC shareholders Q1 2021
NameSharesValueWeighting ↓
Conrad N. Hilton Foundation 63,481$7,847,000100.00%
CPMG Inc 2,896,901$358,115,00055.16%
PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE 140,000$17,307,00026.62%
Corriente Advisors, LLC 525,000$64,901,00015.45%
DUMAC, INC. 76,050$9,401,0007.33%
MADDEN SECURITIES Corp 35,152$4,345,0002.80%
Biondo Investment Advisors, LLC 113,692$14,055,0002.69%
Duquesne Family Office 749,897$92,702,0002.50%
LBJ Family Wealth Advisors, Ltd. 30,368$3,754,0002.44%
Integral Health Asset Management, LLC 50,000$6,181,0001.84%
View complete list of REATA PHARMACEUTICALS INC shareholders